Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.37
-0.23 (-3.48%)
At close: Aug 11, 2026, 4:00 PM EDT
6.30
-0.07 (-1.10%)
Pre-market: Aug 12, 2026, 4:01 AM EDT

Nuvation Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-149.83-204.63-567.94-75.8-104.2-86.85
Depreciation & Amortization
2.151.740.680.220.20.18
Stock-Based Compensation
35.535.8932.2819.5116.299.27
Other Adjustments
13.685.55417.05-12.47-4.954.41
Change in Receivables
-25.13-3.35-12.72---
Changes in Inventories
-19.38-11.41----
Changes in Accounts Payable
-9.833.13-1.650.07-1.791.86
Changes in Accrued Expenses
22.6412.356.84-0.02-2.327.45
Changes in Unearned Revenue
-5.1-7.873.94---
Changes in Other Operating Activities
-2.72-4.83-8.910.490.66-4.52
Operating Cash Flow
-120.52-173.43-130.41-68-96.11-68.19
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.4-0.35-0.16-0.07-0.37-0.28
Sale of Property, Plant & Equipment
---0.010.01-
Purchases of Intangible Assets
--8----
Purchases of Investments
-361.88-354.42-339.65-703.37-520.31-609.3
Proceeds from Sale of Investments
323.1462.29450.08712.35584.12154.91
Other Investing Activities
--12.43---
Investing Cash Flow
-47.1899.52122.78.9263.46-454.67

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
11.2210.112.61---
Long-Term Debt Repaid
-72.26-12.39-17.16---
Net Long-Term Debt Issued (Repaid)
-61.06197.71-4.55---
Issuance of Common Stock
14.711.424.890.631.33625.53
Net Common Stock Issued (Repurchased)
14.711.424.890.631.33625.53
Other Financing Activities
-1.12-6.6----
Financing Cash Flow
179.14202.540.330.631.33625.53

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.8-0.270.45---
Net Cash Flow
10.63128.36-6.93-58.45-31.32102.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-120.93-173.78-130.58-68.07-96.48-68.47
Free Cash Flow Growth
------
FCF Margin
-71.17%-276.27%-1658.52%---
Free Cash Flow Per Share
-0.34-0.51-0.49-0.31-0.45-0.35
Levered Free Cash Flow
-223.53-14.16-571.76-75.11-107.82-82.15
Unlevered Free Cash Flow
-150.27-220.3-591.89-99.13-123.35-88.62
SEC Filings: 10-K · 10-Q